Amadix
Early cancer detection in blood
Spain
43 employees
Grant
Total: $4.55M
Biopharma, Biotechnology +3
General Information
Spain
BounceWatch is an independent company data service, not affiliated with Amadix. To contact Amadix, visit amadix.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Amadix compare?
A PDF of Amadix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Amadix soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Spain Market
Biopharma
About Amadix
Business keywords: Molecular Diagnostics, Liquid Biopsy, Cancer Detection, Innovative Diagnostic Tests, Early Detection, Disruptive Technologies, Tumor Detection, Medical Technology
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | €2.50M | 1 |
|
06 Oct 2021 |
| Non Equity Assistance | Undisclosed | 1 |
|
16 Nov 2018 |
| Grant | €50.00K | 1 |
EASME - EU Executive Agency for SMEs
|
01 Jul 2017 |
| Venture Round | €2.00M | 3 |
|
10 Feb 2013 |
Latest News
View All
Amadix Alternatives & Competitors
View All Alternatives
Liquid biopsy company focused on cancer screening with a proprietary platform for detecting precance...
Easy, Accurate & Affordable Blood Based Screening for early detection of cancer and COVID-19 detecti...
FAQ About Amadix
Source: BounceWatch company record for Amadix, https://bouncewatch.com/company/amadix, updated 29 December 2024. When citing, please name BounceWatch and link this page.
